A Study of Dostarlimab in Untreated dMMR/MSI-H Locally Advanced Rectal Cancer

GSK Investigational Site, New York

GSK Investigational Site, Marseille

GSK Investigational Site, Berlin

GSK Investigational Site, Pittsburgh

GSK Investigational Site, Granada

GSK Investigational Site, Milan

GSK Investigational Site, Richmond

GSK Investigational Site, Besançon

GSK Investigational Site, Madrid

GSK Investigational Site, Madrid

GSK Investigational Site, Pessac

GSK Investigational Site, Rennes

GSK Investigational Site, Padua

GSK Investigational Site, Nashville

GSK Investigational Site, Santander

GSK Investigational Site, Düsseldorf

GSK Investigational Site, Valencia

GSK Investigational Site, Frankfurt

GSK Investigational Site, Paris

GSK Investigational Site, Dallas

GSK Investigational Site, München

GSK Investigational Site, Albuquerque

GSK Investigational Site, Los Angeles

GSK Investigational Site, Ottawa

GSK Investigational Site, Toronto

GSK Investigational Site, Montreal

GSK Investigational Site, Sherbrooke

GSK Investigational Site, Dresden

GSK Investigational Site, Roma

GSK Investigational Site, Chiba

GSK Investigational Site, Kanagawa

GSK Investigational Site, Osaka

GSK Investigational Site, Osaka

GSK Investigational Site, Utrecht

GSK Investigational Site, Seoul

GSK Investigational Site, Seoul

GSK Investigational Site, Seoul

GSK Investigational Site, Seoul

GSK Investigational Site, Barcelona

GSK Investigational Site, Leeds West Yorkshire

GSK Investigational Site, London

GSK Investigational Site, Sutton